Skip to main content
Top
Published in: Pediatric Radiology 9/2016

01-08-2016 | Original Article

Imaging features of kaposiform lymphangiomatosis

Authors: Pradeep Goyal, Ahmad I. Alomari, Harry P. Kozakewich, Cameron C. Trenor III, Antonio R. Perez-Atayde, Steven J. Fishman, Arin K. Greene, Raja Shaikh, Gulraiz Chaudry

Published in: Pediatric Radiology | Issue 9/2016

Login to get access

Abstract

Background

Kaposiform lymphangiomatosis is a rare, aggressive lymphatic disorder. The imaging and presenting features of kaposiform lymphangiomatosis can overlap with those of central conducting lymphatic anomaly and generalized lymphatic anomaly.

Objective

To analyze the imaging findings of kaposiform lymphangiomatosis disorder and highlight features most suggestive of this diagnosis.

Materials and methods

We retrospectively identified and characterized 20 children and young adults with histopathological diagnosis of kaposiform lymphangiomatosis and radiologic imaging referred to the vascular anomalies center between 1995 and 2015.

Results

The median age at onset was 6.5 years (range 3 months to 27 years). The most common presenting features were respiratory compromise (dyspnea, cough, chest pain; 55.5%), swelling/mass (25%), bleeding (15%) and fracture (5%). The thoracic cavity was involved in all patients; all patients had mediastinal involvement followed by lung parenchymal disease (90%) and pleural (85%) and pericardial (50%) effusions. The most common extra-thoracic sites of disease were the retroperitoneum (80%), bone (60%), abdominal viscera (55%) and muscles (45%). There was characteristic enhancing and infiltrative soft-tissue thickening in the mediastinum and retroperitoneum extending along the lymphatic distribution.

Conclusion

Kaposiform lymphangiomatosis has overlapping imaging features with central conducting lymphatic anomaly and generalized lymphatic anomaly. Presence of mediastinal or retroperitoneal enhancing and infiltrative soft-tissue disease along the lymphatic distribution, hemorrhagic effusions and moderate thrombocytopenia (50–100,000/μl) should favor diagnosis of kaposiform lymphangiomatosis.
Literature
1.
go back to reference Croteau SE, Kozakewich HP, Perez-Atayde AR et al (2014) Kaposiform lymphangiomatosis: a distinct aggressive lymphatic anomaly. J Pediatr 164:383–388CrossRefPubMed Croteau SE, Kozakewich HP, Perez-Atayde AR et al (2014) Kaposiform lymphangiomatosis: a distinct aggressive lymphatic anomaly. J Pediatr 164:383–388CrossRefPubMed
2.
go back to reference Safi F, Gupta A, Adams D et al (2014) Kaposiform lymphangiomatosis, a newly characterized vascular anomaly presenting with hemoptysis in an adult woman. Ann Am Thorac Soc 11:92–95CrossRefPubMed Safi F, Gupta A, Adams D et al (2014) Kaposiform lymphangiomatosis, a newly characterized vascular anomaly presenting with hemoptysis in an adult woman. Ann Am Thorac Soc 11:92–95CrossRefPubMed
3.
go back to reference Detaille T, Joomye R, Barrea C et al (2010) Acute life-threatening presentation of unknown lymphatic malformation. Am J Emerg Med 28:1062.e1061–1063CrossRef Detaille T, Joomye R, Barrea C et al (2010) Acute life-threatening presentation of unknown lymphatic malformation. Am J Emerg Med 28:1062.e1061–1063CrossRef
4.
go back to reference Debelenko L, Marler J, Perez-Atayde A et al (2004) Kaposiform lymphangiomatosis: an aggressive variant of lymphangiomatosis (LA). In: Laboratory investigation, vol. 84. Nature Publishing Group, New York, p 269 Debelenko L, Marler J, Perez-Atayde A et al (2004) Kaposiform lymphangiomatosis: an aggressive variant of lymphangiomatosis (LA). In: Laboratory investigation, vol. 84. Nature Publishing Group, New York, p 269
5.
6.
go back to reference Fernandes VM, Fargo JH, Saini S et al (2015) Kaposiform lymphangiomatosis: unifying features of a heterogeneous disorder. Pediatr Blood Cancer 62:901–904CrossRefPubMed Fernandes VM, Fargo JH, Saini S et al (2015) Kaposiform lymphangiomatosis: unifying features of a heterogeneous disorder. Pediatr Blood Cancer 62:901–904CrossRefPubMed
7.
go back to reference Enjolras O, Mulliken JB, Kozakewich HP (2013) Vascular tumors and tumors like lesions. In: Mulliken JB, Burrows PE, Fishman SJ (eds) Mulliken and Young’s vascular anomalies: hemangiomas and malformations, 2nd edn. Oxford University Press, New York, pp 259–326CrossRef Enjolras O, Mulliken JB, Kozakewich HP (2013) Vascular tumors and tumors like lesions. In: Mulliken JB, Burrows PE, Fishman SJ (eds) Mulliken and Young’s vascular anomalies: hemangiomas and malformations, 2nd edn. Oxford University Press, New York, pp 259–326CrossRef
8.
go back to reference Fishman SJ (2013) Slow-flow vascular malformations. In: Mulliken JB, Burrows PE, Fishman SJ (eds) Mulliken & Young’s vascular anomalies: hemangiomas and malformations. Oxford University Press, New York Fishman SJ (2013) Slow-flow vascular malformations. In: Mulliken JB, Burrows PE, Fishman SJ (eds) Mulliken & Young’s vascular anomalies: hemangiomas and malformations. Oxford University Press, New York
9.
go back to reference Tazelaar HD, Kerr D, Yousem SA et al (1993) Diffuse pulmonary lymphangiomatosis. Hum Pathol 24:1313–1322CrossRefPubMed Tazelaar HD, Kerr D, Yousem SA et al (1993) Diffuse pulmonary lymphangiomatosis. Hum Pathol 24:1313–1322CrossRefPubMed
10.
go back to reference Lala S, Mulliken JB, Alomari AI et al (2013) Gorham-Stout disease and generalized lymphatic anomaly — clinical, radiologic, and histologic differentiation. Skeletal Radiol 42:917–924CrossRefPubMed Lala S, Mulliken JB, Alomari AI et al (2013) Gorham-Stout disease and generalized lymphatic anomaly — clinical, radiologic, and histologic differentiation. Skeletal Radiol 42:917–924CrossRefPubMed
11.
go back to reference Hammill AM, Wentzel M, Gupta A et al (2011) Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer 57:1018–1024CrossRefPubMed Hammill AM, Wentzel M, Gupta A et al (2011) Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer 57:1018–1024CrossRefPubMed
12.
go back to reference Reinglas J, Ramphal R, Bromwich M (2011) The successful management of diffuse lymphangiomatosis using sirolimus: a case report. Laryngoscope 121:1851–1854PubMed Reinglas J, Ramphal R, Bromwich M (2011) The successful management of diffuse lymphangiomatosis using sirolimus: a case report. Laryngoscope 121:1851–1854PubMed
13.
go back to reference Lyons LL, North PE, Mac-Moune Lai F et al (2004) Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol 28:559–568CrossRefPubMed Lyons LL, North PE, Mac-Moune Lai F et al (2004) Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol 28:559–568CrossRefPubMed
14.
go back to reference Zukerberg LR, Nickoloff BJ, Weiss SW (1993) Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol 17:321–328CrossRefPubMed Zukerberg LR, Nickoloff BJ, Weiss SW (1993) Kaposiform hemangioendothelioma of infancy and childhood. An aggressive neoplasm associated with Kasabach-Merritt syndrome and lymphangiomatosis. Am J Surg Pathol 17:321–328CrossRefPubMed
15.
go back to reference Croteau SE, Liang MG, Kozakewich HP et al (2013) Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals. J Pediatr 162:142–147CrossRefPubMed Croteau SE, Liang MG, Kozakewich HP et al (2013) Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals. J Pediatr 162:142–147CrossRefPubMed
16.
go back to reference Enjolras O, Mulliken JB, Wassef M et al (2000) Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol 42:225–235CrossRefPubMed Enjolras O, Mulliken JB, Wassef M et al (2000) Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol 42:225–235CrossRefPubMed
17.
go back to reference Haisley-Royster C, Enjolras O, Frieden IJ et al (2002) Kasabach-Merritt phenomenon: a retrospective study of treatment with vincristine. J Pediatr Hematol Oncol 24:459–462CrossRefPubMed Haisley-Royster C, Enjolras O, Frieden IJ et al (2002) Kasabach-Merritt phenomenon: a retrospective study of treatment with vincristine. J Pediatr Hematol Oncol 24:459–462CrossRefPubMed
Metadata
Title
Imaging features of kaposiform lymphangiomatosis
Authors
Pradeep Goyal
Ahmad I. Alomari
Harry P. Kozakewich
Cameron C. Trenor III
Antonio R. Perez-Atayde
Steven J. Fishman
Arin K. Greene
Raja Shaikh
Gulraiz Chaudry
Publication date
01-08-2016
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Radiology / Issue 9/2016
Print ISSN: 0301-0449
Electronic ISSN: 1432-1998
DOI
https://doi.org/10.1007/s00247-016-3611-1

Other articles of this Issue 9/2016

Pediatric Radiology 9/2016 Go to the issue